Tilsotolimod sodium
Tilsotolimod (IMO-2125) sodium is a TLR9 agonist. Tilsotolimod sodium activates the TLR9 signaling pathway, triggers downstream pro-inflammatory and immunostimulatory pathways, enhances the uptake and killing of cancer cells, and induces adaptive immune responses. Tilsotolimod sodium is applicable to research related to melanoma and colorectal cancer.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2089768-67-0
- Fòrmula: C223H262N74Na22O115P22S22
- Peso molecular:7228 (free acid)
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
Actividad biológica
Tilsotolimod sodium exerts anti-tumor activity either alone or in combination with Ipilimumab (HY-P9901) and/or Nivolumab (HY-P9903)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
No. CAS 2089768-67-0
-
Peso molecular 7228 (free acid)
-
Fòrmula C223H262N74Na22O115P22S22
-
SMILES
[Tilsotolimod (sodium)]
-
Synonyms
IMO-2125 sodium
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)